TP53 autoantibody can detect CA125 screen negative ovarian cancer cases and can be elevated prior to CA125 in preclinical ovarian cancer

被引：2
|
作者：
Yang, Wei-Lei [1 ]
Simmons, Archana [1 ]
Lu, Zhen [1 ]
Baggerly, Keith [1 ]
Lu, Karen [1 ]
Gentry-Maharaj, Alex [2 ]
Menon, Usha [2 ]
Jacobs, Ian [3 ]
Bast, Robert C. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] UCL, London WC1E 6BT, England
[3] Univ Manchester, Manchester M13 9PL, Lancs, England
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-2838
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2838
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Elevation of TP53 Autoantibody Before CA125 in Preclinical Invasive Epithelial Ovarian Cancer
    Yang, Wei-Lei
    Gentry-Maharaj, Aleksandra
    Simmons, Archana
    Ryan, Andy
    Fourkala, Evangelia Ourania
    Lu, Zhen
    Baggerly, Keith A.
    Zhao, Yang
    Lu, Karen H.
    Bowtell, David
    Jacobs, Ian
    Skates, Steven J.
    He, Wei-Wu
    Menon, Usha
    Bast, Robert C., Jr.
    CLINICAL CANCER RESEARCH, 2017, 23 (19) : 5912 - 5922
  • [2] HE4 antigen-autoantibody complexes complement CA125 for detecting early stage ovarian cancer and can be elevated with CA125 in preclinical ovarian cancer
    Yang, Wei-Lei
    Lu, Zhen
    Lu, Karen H.
    Menon, Usha
    Kobayashi, Makoto
    Hanash, Samir
    Skates, Steven
    Bast, Robert C.
    CANCER RESEARCH, 2018, 78 (13)
  • [3] CA125 in ovarian cancer
    Scholler, Nathalie
    Urban, Nicole
    BIOMARKERS IN MEDICINE, 2007, 1 (04) : 513 - 523
  • [4] SERIAL CA125 CAN DETECT OVARIAN CANCER IN THE ABSENCE OF ULTRASOUND ABNORMALITIES
    Menon, U.
    Ryan, A.
    Kalsi, J.
    Gentry-Maharaj, A.
    Dawnay, A.
    Habib, M.
    Apostolidou, S.
    Singh, N.
    Benjamin, E.
    Burnell, M.
    Davies, S.
    Sharma, A.
    Gunu, R.
    Godfrey, K.
    Lopes, A.
    Oram, D.
    Herod, J.
    Williamson, K.
    Seif, M.
    Jenkins, H.
    Mould, T.
    Woolas, R.
    Murdoch, J.
    Dobbs, S.
    Nazar, N.
    Leeson, S.
    Cruickshank, D.
    Scott, I.
    Fallowfield, L.
    Widschwendter, M.
    Reynolds, K.
    Campbell, S.
    Parmar, M.
    Skates, S. J.
    Jacobs, I.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 46 - 47
  • [5] Ovarian hemangioma with elevated CA125 and ascites mimicking ovarian cancer
    Erdemoglu, E
    Kamaci, M
    Özen, S
    Sahin, HG
    Kolusari, A
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2006, 27 (02) : 195 - 196
  • [6] CA125 Immune Complexes in Ovarian Cancer Patients with Low CA125 Concentrations
    Cramer, Daniel W.
    O'Rourke, Dennis J.
    Vitonis, Allison F.
    Matulonis, Ursula A.
    DiJohn-son, Daniel A.
    Sluss, Patrick M.
    Crum, Christopher P.
    Liu, Brian C. -S.
    CLINICAL CHEMISTRY, 2010, 56 (12) : 1889 - 1892
  • [7] Ovarian cancer: the duplicity of CA125 measurement
    Karam, Amer K.
    Karlan, Beth Y.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2010, 7 (06) : 335 - 339
  • [8] Ovarian cancer: the duplicity of CA125 measurement
    Amer K. Karam
    Beth Y. Karlan
    Nature Reviews Clinical Oncology, 2010, 7 : 335 - 339
  • [9] Tumor marker CA125 in ovarian cancer
    Tuxen, MK
    JOURNAL OF TUMOR MARKER ONCOLOGY, 2001, 16 (01): : 49 - 68
  • [10] CA125 and Ovarian Cancer: A Comprehensive Review
    Charkhchi, Parsa
    Cybulski, Cezary
    Gronwald, Jacek
    Wong, Fabian Oliver
    Narod, Steven A.
    Akbari, Mohammad R.
    CANCERS, 2020, 12 (12) : 1 - 29
12345